Ascendia Pharmaceutical Solutions Fourth Annual Technical Workshop Sets Attendance Record

Oct 1, 2026, 2:34:34 PM

Ascendia Pharmaceutical Solutions Supports Prescription Drug User Fee Act (PDUFA) Renewal

Aug 26, 2026, 12:35:15 PM

Fast, Flexible and First Time Right Philosophy Creates Efficient Drug Development

Aug 10, 2026, 2:52:59 PM

How Lipid Nanoparticles Enable Nucleic Acid Delivery

Jul 2, 2026, 4:57:54 PM

Ascendia Pharmaceutical Solutions Puts Customers First During Formulation Development & Manufacturing

May 18, 2026, 2:50:25 PM

Ascendia Pharmaceutical Solutions Founder and CEO Named EY Entrepreneur Of The Year® 2026 New Jersey Finalist

Apr 24, 2026, 6:14:51 PM

SEDDS/SNEDDS – A Self Emulsifying Technology for Delivery of an Array of Small and Large Molecules

Apr 29, 2025, 1:05:33 PM

Ascendia Pharmaceutical Solutions Expands Business Development Team

Feb 20, 2025, 5:03:45 PM

Ascendia Pharmaceuticals Named to Inc. 5000 List for Third Consecutive Year

Sep 8, 2022, 12:00:00 AM

Steps to Overcome Challenges Associated with Biologic Formulation Development

Aug 22, 2022, 12:00:00 AM

Ascendia Pharmaceuticals Included in 2022 United States Life Sciences Report

Jul 7, 2022, 12:00:00 AM

Ascendia Pharmaceuticals Provides Perspective on Life Science Market During CPHI North America

Jun 27, 2022, 12:00:00 AM